|
|
|
51-200 employees
View all
|
|
Biotechnology
|
|
610 Main St, Cambridge, Massachusetts 02139, US
|
|
ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome – vast stretches of uncharted genetic material that have long been dismissed as “junk DNA.” With several drug targets identified and multiple discovery programs underway, ROME is moving rapidly to leverage this new frontier in biology. To lead this exploration, ROME has assembled a team of world-class leaders across fields including oncology, immunology, virology and machine learning. ROME was launched in April 2020 and was incubated at GV, in collaboration with ARCH Venture Partners and Partners Innovation Fund. ROME is based in Cambridge, Mass. For more information, please visit www.rometx.com.
|
ROME Therapeutics Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
75.00%
|
The widely used ROME Therapeutics email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.
To contact ROME Therapeutics customer service number in your country click here to find.
Monika Schlawinsky is the CEO of ROME Therapeutics. To contact Monika Schlawinsky email at [email protected] or [email protected]. Or you may call +1.3399330303
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.